Tuesday, December 18, 2018, 10:00 am to 11:00 am
Neuroscience Center (6001 Executive Boulevard, Bethesda, MD), Conference Rooms C & D
The next lecture in the 13th annual National Institute of Mental Health (NIMH) Director's Innovation Speaker Series, which consists of talks dedicated to innovation, invention, and scientific discovery, will be given by Dr. Margarita Alegría. In her talk, Dr. Alegría will describe the need for a paradigmatic shift in how mental health services are delivered and by whom, to be ready for the 21st century. Emphasis will be placed on major challenges confronted by groups typically excluded in mental healthcare and the potential changes needed at the levels of policy, healthcare system, and patient-provider interactions. Dr. Alegría will review recent research and propose promising approaches to achieve mental health equity.
Dr. Alegría is the Chief of the Disparities Research Unit at Massachusetts General Hospital and a Professor in the Departments of Medicine and Psychiatry at Harvard Medical School. She has published on topics such as improvement of health care services delivery for diverse racial and ethnic populations, conceptual and methodological issues with multicultural populations, and ways to involve communities into the design and implementation of health services.
This event is open without prior registration to all NIH staff and the general public.
Tuesday, January 22, 2019, 8:00 am to 4:45 pm (registration required)
NIH Clinical Center (Building 10), Masur Auditorium
Please join the Department of Transfusion Medicine at the NIH Clinical Center and the University of California San Francisco’s American Course on Drug Development and Regulatory Sciences for a cell therapy state of the art workshop. Topics will include cancer immunotherapy; adoptively transferred T-cell therapy for viral infections; regulatory considerations for cellular immunotherapies; approval of Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel); cell dosing; challenges in process and analytical development of cell therapies; exploratory initial studies and manufacturing; industry perspective on large scale manufacture of autologous cell-based immunotherapies; clinical trial design and adaptive approaches in cell therapy clinical trials; clinical design of early phase cell therapy clinical trials; and third party universal donor immunotherapies using CRISPR technologies and new cellular immunotherapy for solid tumors.
Advanced registration is required. Discounted rates are available for non-NIH government/academic registrants. If you are an NIH employee, your registration fee is waived. Please contact acdrs@ucsf.edu to register.
Thursday, April 11, 2019 to Friday, April 12, 2019 (register by March 25)
NIH Natcher Auditorium (Building 45)
RNA biology has emerged as one of the most influential areas in modern biology and biomedicine. The discovery of numerous new classes of RNAs and their function in a wide spectrum of biological processes has revolutionized molecular biology and has profound implications for clinical sciences. Key areas of current research include the elucidation of RNA biogenesis and structure, the identification of functions for various classes of RNAs, establishing the role of RNA in disease, and the exploration of RNA-based-and RNA-targeted therapies.
Organized by the National Cancer Institute (NCI) Center for Cancer Research's Initiative in RNA Biology, this symposium will bring together internationally renowned experts in the field of RNA biology, with a focus on RNA processing; RNA structure and mechanism; non-classical RNAs; and RNA therapy. The symposium offers the opportunity to learn more about the current status of RNA biology in development and disease, share research, network with leading figures in the field, and discuss the use and implications of these advances for clinical applications.
